Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
In a study that demonstrates the promise of cell-based therapies for diseases that have proved intractable to modern medicine, a team of scientists from the University of Wisconsin-Madison has shown it is possible to rescue the dying neurons characteristic of amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disorder also known as Lou Gehrig's disease.
In an effort to strengthen and sustain its leadership in the companion fields of stem cell research and regenerative medicine, the University of Wisconsin-Madison will establish a new Stem Cell and Regenerative Medicine Center.
For the millions of Americans whose vision is slowly ebbing due to degenerative diseases of the eye, the lowly neural progenitor cell may be riding to the rescue. In a study in rats, neural progenitor cells derived from human fetal stem cells have been shown to protect the vision of animals with degenerative eye disease similar to the kinds of diseases that afflict humans.
Using neural stem cells derived from the fetal brains of rats, a team of Wisconsin scientists has devised a rudimentary blood-brain barrier in the lab.
One of the great challenges for treating Parkinson's diseases and other neurodegenerative disorders is getting medicine to the right place in the brain.
The WiCell Research Institute has been selected by the National Institutes of Health (NIH) to establish the federal government's first and only National Stem Cell Bank (NSCB), it was announced today at a news conference in Madison.
A photograph of a neural stem cell taken by Waisman researcher Su Chun Zhang is featured on the cover of a new publication, Guidelines for Human Embryonic Stem Cell Research.
In an effort to develop new techniques to repair and protect the nervous system in multiple sclerosis patients, including the use of human stem cells, the National Multiple Sclerosis Society has awarded $3.4 million to a team of UW-Madison scientists.
At a meeting of stem cell researchers in Madison today (April 26), UW-Madison professor of anatomy and neurology Clive Svendsen announced the establishment of a new regenerative medicine program and an interdisciplinary postdoctoral training program that will advance stem cell research across the university.
Unveiling a delivery method that may one day help surgeons treat the deadly neurodegenerative disease amyotrophic lateral sclerosis (ALS), researchers at the UW-Madison have inserted engineered human stem cells into the spinal cords of ALS-afflicted rats.
